Management of bronchiectasis in adults

Area of Science:

• Pulmonology
• Respiratory Medicine

Background:

• Bronchiectasis, a chronic lung disease, is characterized by cough, sputum, and recurrent exacerbations.
• Causes are diverse, including infections, COPD, asthma, immunodeficiency, and connective tissue diseases, with many cases remaining idiopathic.
• Recent guidelines from Europe and Australia reflect growing evidence in bronchiectasis management.

Purpose of the Study:

• To summarize current understanding and management of bronchiectasis unrelated to cystic fibrosis.
• To highlight recent advancements in treatment and the need for further research into disease pathogenesis and burden.

Main Methods:

• Review of current evidence and management guidelines for bronchiectasis.
• Discussion of diagnostic criteria (high-resolution computed tomography chest scan).
• Emphasis on personalized airway clearance and emerging evidence for pharmacotherapy.

Main Results:

• Effective airway clearance by respiratory physiotherapists is the cornerstone of management.
• Long-term oral macrolide antibiotics are evidenced to reduce exacerbation frequency in selected patients.
• Routine use of inhaled corticosteroids and long-acting bronchodilators is generally not recommended unless co-existing COPD or asthma is present.

Conclusions:

• Bronchiectasis management requires personalized airway clearance and consideration of specific treatments.
• Further research, supported by registries like the Australian Bronchiectasis Registry, is crucial to define disease burden and improve understanding.
• The increasing prevalence worldwide necessitates ongoing investigation and improved diagnostic classification systems.